Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyoshi Harashima

Showing results (241-250 of 485) with videos related to

Pageof 49
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 14, 2023
Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in miceMahmoud A Younis, Yusuke Sato, Yaser H A Elewa, et al.
Chemical Communications (Cambridge, England)|January 3, 2020
The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrin-type photosensitizer in combination with MITO-PorterSatrialdi, Reina Munechika, Vasudevanpillai Biju, et al.
Chemical Communications (Cambridge, England)|May 28, 2020
Correction: The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrin-type photosensitizer in combination with MITO-PorterSatrialdi, Reina Munechika, Vasudevanpillai Biju, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2026
A novel bivalent neoantigen vaccine based on mRNA-loaded lipid nanoparticles eradicates hepatocellular carcinoma in miceMahmoud A Younis, Yusuke Sato, Yaser H A Elewa, et al.
Molecular Pharmaceutics|January 25, 2021
GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the LungsYuta Hagino, Ikramy A Khalil, Seigo Kimura, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
RNA aptamers for targeting mitochondria using a mitochondria-based SELEX methodYuri Tawaraya, Mamoru Hyodo, Mst Naznin Ara, et al.
Plos One|December 11, 2012
Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodMst Naznin Ara, Mamoru Hyodo, Noritaka Ohga, et al.
Journal of Drug Targeting|May 9, 2014
Comparative assessments of crucial factors for a functional ligand-targeted nanocarrierMd Nazir Hossen, Kazuaki Kajimoto, Ryo Tatsumi, et al.
Biomaterials|July 16, 2019
Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistributionTakashi Nakamura, Yuma Yamada, Yusuke Sato, et al.
Nucleic Acids Research|January 22, 2015
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvantNaoya Miura, Sharif M Shaheen, Hidetaka Akita, et al.
Pageof 49

Showing results (241-250 of 485) with videos related to

Sort By:
Pageof 49
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 14, 2023
Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in miceMahmoud A Younis, Yusuke Sato, Yaser H A Elewa, et al.
Chemical Communications (Cambridge, England)|January 3, 2020
The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrin-type photosensitizer in combination with MITO-PorterSatrialdi, Reina Munechika, Vasudevanpillai Biju, et al.
Chemical Communications (Cambridge, England)|May 28, 2020
Correction: The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrin-type photosensitizer in combination with MITO-PorterSatrialdi, Reina Munechika, Vasudevanpillai Biju, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2026
A novel bivalent neoantigen vaccine based on mRNA-loaded lipid nanoparticles eradicates hepatocellular carcinoma in miceMahmoud A Younis, Yusuke Sato, Yaser H A Elewa, et al.
Molecular Pharmaceutics|January 25, 2021
GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the LungsYuta Hagino, Ikramy A Khalil, Seigo Kimura, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
RNA aptamers for targeting mitochondria using a mitochondria-based SELEX methodYuri Tawaraya, Mamoru Hyodo, Mst Naznin Ara, et al.
Plos One|December 11, 2012
Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodMst Naznin Ara, Mamoru Hyodo, Noritaka Ohga, et al.
Journal of Drug Targeting|May 9, 2014
Comparative assessments of crucial factors for a functional ligand-targeted nanocarrierMd Nazir Hossen, Kazuaki Kajimoto, Ryo Tatsumi, et al.
Biomaterials|July 16, 2019
Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistributionTakashi Nakamura, Yuma Yamada, Yusuke Sato, et al.
Nucleic Acids Research|January 22, 2015
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvantNaoya Miura, Sharif M Shaheen, Hidetaka Akita, et al.
Pageof 49